You have read all your free articles, to continue reading subscribe to read the rest of this content.
Oncopeptides has agreed with Kancera to take over Kancera’s drug development facility in Solna, Sweden. The agreement is an important step in the development of Oncopeptides’ pre-clinical operations and marks an additional reinforcement of the company's research capacity, it states. OncopeptiAlready a subscriber Login You have read all your free…
Tromsø based ArcticZymes AS, a subsidiary of ArcticZymes Technologies, has entered into a supply and distribution agreement with precision medicine company Jiangsu Simcere Diagnostics, Nanjing, China. "This is just the beginning of a long-term relationship together where ArcticZymes' novel enzymAlready a subscriber Login You have read all your free articles,…
Scandion Oncology A/S has obtained DKK 5 million from Innovation Fund Denmark for the clinical development of SCO-101 in metastatic pancreatic cancer. The grant of DKK 5 million from Innovation Fund Denmark is earmarked for the clinical phase II development of SCO-101 in metastatic pancreatic canAlready a subscriber Login You…
LEO Pharma announces an investment in the biotechnology company Novopyxis to support the development of an early-stage drug delivery device designed to increase the penetration of topical treatments in the skin. The hand-held aerosol device will be clinically tested on people with alopecia. AlopeAlready a subscriber Login You have read…
